Summary: Data from a single EEG electrode may predict cognitive decline, including dementia, in people with Parkinson’s disease.
A University of Iowa study found that reduced strength of specific low-frequency brain waves—delta and theta rhythms—measured over the frontal cortex strongly correlates with cognitive dysfunction in Parkinson’s disease (PD). Because electroencephalography (EEG) is non-invasive and inexpensive, these measurements could become a practical biomarker to help diagnose and monitor cognitive impairment in PD and guide treatment adjustments.
The results also indicate that EEG signals could assist clinicians in tracking cognitive side effects from Parkinson’s treatments and evaluating the effectiveness of new therapies aimed at cognitive symptoms.
Key Facts:
- Cognitive decline is a common and impactful feature of Parkinson’s disease: about 30% of patients show cognitive symptoms at diagnosis and up to 80% develop cognitive problems later in the disease course.
- Reduced amplitude of frontal delta (1–4 Hz) and theta (4–7 Hz) brain waves during task engagement is strongly associated with poorer cognitive performance in PD.
- Single-electrode EEG recordings may offer a low-cost, non-invasive method to screen for cognitive impairment, monitor treatment-related cognitive effects, and aid development of cognitive therapies for Parkinson’s disease.
Source: University of Iowa
Brief overview
In this study, just a few minutes of EEG recorded from a single electrode at the cranial vertex (Cz) while patients performed simple cognitive tasks provided predictive information about their cognitive status. The research team reports that weaker cue-evoked mid-frontal delta and theta activity corresponded to slower responses and worse performance across tasks, offering a robust neural marker of cognitive dysfunction in PD.
Why this matters
Clinicians commonly assess cognition with paper-based neuropsychological tests that require trained personnel and are limited by practice effects when repeated. EEG provides an objective physiological measure that can be recorded repeatedly, continuously, and in varied settings such as clinics, nursing homes, or patients’ homes. This makes EEG a promising tool for routine cognitive monitoring and for evaluating how medications or brain stimulation therapies affect cognition over time.
Study design and main findings
The study included 100 people with PD spanning the full cognitive spectrum—from cognitively normal to mild cognitive impairment to dementia—and 49 demographically matched control participants. All participants completed three established tasks that probe cognitive control: the Simon task, an oddball task, and an interval-timing task. While participants performed these tasks, the investigators measured cue-evoked delta and theta rhythms from a single mid-frontal electrode (Cz).
Across tasks, diminished mid-frontal delta/theta power was consistently associated with longer response times and poorer cognitive scores. Within the PD group, a principal component summarizing the evoked EEG features from Cz correlated with clinical measures of cognition, including the Montreal Cognitive Assessment (MoCA) and an NIH Toolbox executive function score, supporting the link between these EEG rhythms and clinical cognitive function.
Interpretation and clinical implications
The authors suggest that a core deficit in PD-related cognitive decline may be a reduced ability to recruit basic cue-engagement processes—captured by mid-frontal delta/theta activity—when prompted to pay attention and respond. Because the effect appeared simply when participants had to attend to a cue and act, the measure could be obtained with very simple tasks and a single electrode. This simplicity could enable widespread screening for cognitive impairment and provide a way to track changes over time or in response to therapy.
An important practical implication is the potential to use cueing strategies therapeutically: prompting patients to engage (for example, with verbal or visual cues) could temporarily improve task performance, suggesting new rehabilitation approaches for occupational, physical, or speech therapy in PD.
Next steps
The research team plans to investigate the mechanisms linking reduced delta/theta rhythms to cognitive decline in PD and to refine how EEG might be applied as a diagnostic or therapeutic tool. Future work will explore whether EEG measures can reliably detect cognitive change over time and whether interventions that restore or enhance these low-frequency rhythms can improve cognition.
The research team included Nandakumar Narayanan, MD, PhD (senior author), Arun Singh, PhD, Rachel Cole, Arturo Espinoza, Jan Wessel, and James Cavanagh. Funding was provided in part by grants from the National Institute of Neurological Disorders and Stroke.
About this Parkinson’s disease research news
Author: Jennifer Brown
Source: University of Iowa
Contact: Jennifer Brown – University of Iowa
Image: The image is credited to Neuroscience News
Original Research: Open access. Title: “Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson’s disease” by Nandakumar Narayanan et al., Journal of Neurology, Neurosurgery & Psychiatry.
Abstract
Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson’s disease
Background
Cognitive dysfunction is a major feature of Parkinson’s disease, but its underlying pathophysiology is not fully understood. One hypothesis is that abnormal low-frequency cortical rhythms that support cognitive engagement—specifically mid-frontal delta and theta—are deficient in PD. This study tested whether cue-evoked mid-frontal delta/theta rhythms predict cognitive dysfunction.
Method
The investigators recruited 100 patients with PD and 49 demographically similar control participants. Participants completed cognitive control tasks (Simon, oddball, interval-timing). The analysis focused on cue-evoked delta (1–4 Hz) and theta (4–7 Hz) activity recorded from a single mid-frontal electrode (Cz) across patients who were cognitively normal, had mild cognitive impairment, or had dementia related to PD.
Results
PD-related cognitive dysfunction was associated with increased response latencies and decreased mid-frontal delta power across tasks. Within the PD group, the principal component summarizing evoked EEG features from Cz correlated with clinical cognitive measures, including the MoCA (r = 0.34) and an NIH Toolbox executive function score (r = 0.46).
Conclusions
Cue-evoked mid-frontal delta/theta rhythms relate directly to cognition in PD. The data suggest that decreased delta/theta activity underlies aspects of PD-related cognitive dysfunction and support the potential development of these EEG measures as biomarkers and targets for therapies addressing cognitive symptoms in Parkinson’s disease.